Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России, Санкт-Петербург, Россия
Список исп. литературыСкрыть список 1. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 2005; 186: 411–22. 2. Pessina MA, Hoyt RF, Goldshtein JI, Traish AM. Differential effects of estradiol, progesterone and testosterone on vaginal structural integrity. Endocrinology 2006; 147: 691–9. 3. Waite LJ, Iveniuk J, Laumann EO, McClintock MK. Sexuality in Older Couples Individual and Dyadic Characteristics. Arch Sex Behav 2017; 46 (2): 605–18. 4. Стеняева Н.Н., Хритинин Д.В., Чаусов А.А. Гинекологические заболевания как предикторы женской сексуальной дисфункции. Гинекология. 2021; 23 (2): 149–54. [Stenyaeva N.N., Chritinin D.V., Chausov A.A. Ginekologicheskie zabolevaniya kak prediktory zhenckoi sexual’noy disfunktsii. Ginekologia. 2021; 23 (2): 149–54 (in Russian).] 5. Гоготадзе И.Н., Федорова А.И. Синдром поликистозных яичников в практике подросткового гинеколога: возможности профилактики, принципы терапии. Гинекология. 2017; 19 (2): 19–24. [Gogotadze I.N., Fedorova A.I. Sindrom polikistoznykh yaichnikov v praktike podrostkovogo ginekologa: vozmozhnosti profilaktiki, printsipy terapii. Ginekologia. 2017; 19 (2): 19–24 (in Russian).] 6. Андреева Е.Н., Шереметьева Е.В., Григорян О.Р., Дедов И.И. Психологические особенности больных при различных фенотипах синдрома поликистозных яичников. Проблемы репродукции. 2013; 3: 24–32. [Andreeva E.N., Sheremetyeva E.V., Grigoryan O.R., Dedov I.I. Psihologicheskie osobennosti bol’nykhpri razlichnykh fenotipakh sindroma polikistoznykh yaichnikov. Problemy reproduktsii. 2013; 3: 24–32 (in Russian).] 7. Elsenbruch S, Hahn S, Kowalski D et al. Quality of life, psychosocial well-being and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 5801–7. 8. Devison SL et al. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab 2005; 90: 3847–53. 9. Both S, Lew-Starowicz M, Luria M et al. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM). J Sex Med 2019; 16: 1681–95. 10. Huang M, Li G, Liu J et al. Is There an Association Between Contraception and Sexual Dysfunction in Women? A Systematic Review and Meta-analysis Based on Female Sexual Function Index. J Sex Med 2020; 17: 1942–55. 11. Zahradnik HP, Hanjalik-Beck A. Efficacy, safety and sustainability of treatment continuation and results of an oral contraceptive containing 30 pg ethinylestradiole and 2 mg chlormadinone acetate, in long-term usage (up to 45 cycles). An open-label, prospective, non-controlled, office-based Phase III study. Contraception 2008; 77 (5): 337–41. 12. Pluchino N, Lenzi E, Merlini S, Giannini A. Selective effects of chlormadinone acetate on brain allopregnanolone and opioid content. Contraception 2009; 80 (1): 53–62. 13. De Villiers TJ et al. Global Consensus Statement on Menopause Hormone Therapy. Climacteric 2012; 16: 203–4. 14. Santen RJ et al. Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010; 95 (7; Suppl. 1): s1–s66. 15. Федорова А.И. Диспареуния у женщин в пре- и постменопаузальном периоде. Гинекология. 2016; 18 (1): 13–8. [Fedorova A.I. Dispareunia u zhenschin v pre- i postmenopauzal’nom periode. Ginekologia. 2016; 18 (1): 13–8 (in Russian).] 16. Parish SJ, Simon JA, Davis SR et al. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J Sex Med 2021; 18: 849–67. 17. Vercellini P, Somigliana E, Buggio L et al. "I can’t get no satisfaction": deep dyspareunia and sexual functioning in women with rectovaginal endometriosis. Fertil Steril 2012; 98 (6): 1503–11.e1. 18. Vercellini P, Frattariolo MP, Somigliana E et al. Surgical versus low-dose progestin treatment for endometriosis-associated sever deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod 2013; 28: 1221–30. 19. De Graaf AA, D’Hooghe TM, Dunselman GA, WERF EndoCost Consortium et al. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod 2013; 28: 2677–85.